Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
41.55    -1.75 (-4.04%)
Bid:
41.30
Ask:
42.00
Spread: 0.70 (1.695%)
Market Cap: £276.67m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Half-year Report

31 Aug 2017 07:00

RNS Number : 3685P
Derriston Capital PLC
31 August 2017
 

 

DERRISTON CAPITAL PLC

("Derriston" or the "Company")

 

Interim Report for the period ended 30 June 2017

Derriston Capital (Derr) announces its unaudited interim financial results for the period ended 30 June 2017.

 

Period highlights

 

· On 29 December 2016, the Company was admitted to the standard segment of the Official List and to trading on the London Stock Exchange's Main Market 

· Raised £2.3 million cash (gross) through the listing of 25,000,000 new ordinary shares

 

Post period highlight

 

· Change in strategy from investing in medtech to seeking acquisitions within all technology and other high growth sectors.

 

 

Harry Hyman, Chairman of Derriston said: "Admission to the standard list has given Derriston the profile, funding and liquid equity to consider a number of acquisitions.

 

"Given the large number of exciting opportunities we are analysing, the board has decided to widen the scope of Derriston's investment criteria and look at acquisitions within all technology and other high growth sectors."

 

 

For information please contact:

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

 

 

 

CHAIRMAN'S STATEMENT FOR THE PERIOD ENDED 30 JUNE 2017

 

 

Introduction

 

I am pleased to present the unaudited interim results for the period ended 30 June 2017. Derriston floated on to the standard listing of the official list on the London Stock Exchange on 29 December 2016. The Company was created to undertake an acquisition within the medical technology industry.

 

During this period, Derriston recorded a loss of £140,176, the vast majority relating to the formation of the Company and its admission to the standard list. Since float, the Company has lost £7,273. Cash assets at period end were nearly £2.2 million and it has no debts.

 

 

Outlook

 

Given the large number of exciting opportunities we are analysing, the board has decided to widen the scope of Derriston's investment criteria and look at acquisitions within all technology and other high growth sectors

 

I believe this change in strategy can create significant shareholder value and I look forward to updating the market when further progress is made.

 

 

 

Harry Hyman

Chairman

 

31 August 2017

 

 

 

INTERIM STATEMENT OF COMPREHENSIVE INCOME

FOR THE PERIOD FROM 14 NOVEMBER 2016 TO 30 JUNE 2017

 

 

 

 

Period ended

 

 

30.06.2017

 

(Unaudited)

 

Notes

£

 

 

 

Revenue

2

-

 

 

-------------------

Gross profit

 

-

 

 

 

General & administrative expenses

 

(144,403)

 

 

-------------------

Loss from operations before interest

 

(144,403)

 

 

 

Interest income

 

4,192

 

 

--------------------

Loss before tax

 

(140,211)

 

 

 

Tax

 

-

 

 

---------------------

Retained Loss after tax for the period

 

(140,211)

 

 

===========

 

 

 

Retained loss attributable to:

 

 

Owners of the company

 

(140,211)

 

 

---------------------

Loss for period

 

(140,211)

 

 

===========

Total comprehensive loss attributable to:

 

 

Owners of the company

 

(140,211)

 

 

---------------------

Total comprehensive loss for the period

 

(140,211)

 

 

===========

 

 

 

Loss per share

 

 

Basic and diluted

3

(0.68p)

 

 

===========

 

 

INTERIM STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2017

 

 

 

 

As at

 

 

 30.06.2017

 

 

(Unaudited)

 

Notes

£

ASSETS

 

 

 

 

 

Current assets

 

 

Cash and cash equivalents

 

2,193,961

 

 

-----------------------

TOTAL ASSETS

 

2,193,961

 

 

============

 

 

 

 

 

 

EQUITY

 

 

Share capital

4

625,000

Share premium reserve

 

1,706,250

Retained loss

 

(140,211)

 

 

------------------------

TOTAL EQUITY

 

2,191,039

 

 

============

 

 

 

CURRENT LIABILITIES

 

 

Trade and other payables

 

2,922

 

 

------------------------

TOTAL EQUITY AND LIABILITIES

 

2,193,961

 

 

============

 

 

 

 

 

 

 

 

 

INTERIM STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD FROM 14 NOVEMBER 2016 TO 30 JUNE 2017

 

 

 

 

 

 

 

Share

 

 

 

Share

premium

Retained

Total

 

capital

account

loss

equity

 

£

£

£

£

 

 

 

 

 

Balance at 14 November 2016

-

-

-

-

Loss for the period

-

-

(140,211)

(140,211)

 

 

 

 

 

Total comprehensive income for the period

-

-

(140,211)

(140,211)

Share capital issued (net of transaction costs)

625,000

1,706,250

-

2,331,250

Balance at 30 June 2017

625,000

1,706,250

(140,211)

2,191,039

 

 

 

 

 

 

 

INTERIM STATEMENT OF CASH FLOW

FOR THE PERIOD FROM 14 NOVEMBER 2016 TO 30 JUNE 2017

 

 

Period ended

 

30.06.2017

 

£

 

(Unaudited)

Cash flow from operating activities

 

Loss for the period

(140,211)

 

------------------------

Operating cash flows before movements in working capital

(140,211)

Interest income

(4,192)

Increase in receivables

-

Increase in payables

2,922

 

-----------------------

Net cash flow from operating activities

(141,481)

 

 

Cash flow from investing activities

 

Interest income

4,192

 

------------------------

Net cash flow from investing activities

4,192

 

 

Cash flow from financing activities

 

Net proceeds from issue of share capital

2,331,250

 

------------------------

Net cash flow from financing activities

2,331,250

 

 

Net cash inflow for the period

2,193,961

 

------------------------

 

 

Cash and cash equivalents at start of period

-

 

------------------------

Cash and cash equivalents at end of period

2,193,961

 

============

 

 

 

 

 

NOTES TO THE UNAUDITED INTERIM REPORT

FOR THE PERIOD ENDED 30 JUNE 2017

 

1. BASIS OF PREPARATION

 

The interim financial statements have been prepared on a going concern basis and in accordance with the recognition and measurement principles of International Financial Reporting Standards adopted for use in the European Union ("IFRS").

 

The interim financial statements for the period ended 30 June 2017 have not been audited and do not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. 

 

This Interim Financial Report was approved by the Board of Directors on 30 August 2017.

 

Statement of compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard ('IAS') 34 - Interim Financial Reporting as adopted by the European Union. Accordingly the interim financial statements do not include all of the information or disclosures required in the annual financial statements. 

 

2. TURNOVER AND SEGMENTAL ANALYSIS

 

All of the Company's activity and income and expenses in the period ended 30 June 2017 were incurred in the United Kingdom, and relate to Derriston's ongoing investment activities.

 

3. LOSS PER SHARE

 

The calculation of the basis and diluted earnings per share is based on the following data:

 

Period to

 

30.6.2017

Earnings

 

Earnings for the purposes of basic earnings per share net loss for the

 

period attributable to equity holders of the company

(140,211)

Number of shares

 

Weighted average number of ordinary shares in issue

20,529,476

 

The denominator for the purpose of calculating the basic earnings per share has been adjusted to reflect all capital raisings.

 

4.

SHARE CAPITAL

Number of

Nominal value

Premium

 

 

 

shares

£

£

 

 

 

a) Issued and Fully Paid:

 

 

 

 

 

 

 

 

 

 

 

 

 

14 November 2016

2,250,000

£56,250

-

 

 

 

29 December 2016

22,750,000

£568,750

£1,706,250

 

 

 

 

--------------------------

-------------------------

------------------------

 

 

 

As at 30 June 2017

25,000,000

£625,000

£1,706,250

 

 

 

 

==============

=============

=============

 

 

 

 The nominal value of the shares is £0.025

 

 

 

 

 

5. AVAILABILITY OF INTERIM RESULTS

 

Copies of the Interim Results for the period to 30 June 2017 are available from the Company's registered address and will be available on the Company's website, later today.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SDAESSFWSEIA
Date   Source Headline
4th Jun 20264:30 pmRNSResults of 2026 Annual General Meeting
4th Jun 20267:00 amRNSAGM Statement
13th May 20266:00 pmRNSNotice of AGM
7th May 20267:00 amRNSFirst Quarter Trading Update
30th Apr 20265:00 pmRNSHolding(s) in Company
24th Apr 20265:45 pmRNSAnnual Report and Accounts
15th Apr 20267:00 amRNSNotice of Q1 Trading Update
26th Mar 202612:58 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAudited 2025 Results
26th Feb 20267:00 amRNSNotice of Results
26th Jan 20267:00 amRNSFourth Quarter Trading Update
1st Dec 20257:00 amRNSTotal Voting Rights
24th Nov 20257:00 amRNSTrading Update
14th Nov 202512:15 pmRNSBoard Changes
6th Nov 20257:01 amRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Trading Update
5th Nov 20257:00 amRNSIssue of Shares
17th Oct 20259:00 amRNSNotice of Q3 Trading Update
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSIssue of Shares
15th Sep 20257:00 amRNSInterim Results for 2025
1st Sep 202511:04 amRNSTotal Voting Rights and Capital
22nd Aug 20257:00 amRNSNotice of Results
15th Aug 20257:00 amRNSIssue of Shares
11th Aug 20257:00 amRNSResponse to Press Speculation
1st Aug 20259:15 amRNSTotal Voting Rights
25th Jul 20257:00 amRNSIssue of Shares
17th Jul 20253:02 pmRNSHolding(s) in Company
3rd Jul 20254:30 pmRNSBoard Change
4th Jun 20253:03 pmRNSResult of AGM
4th Jun 20257:00 amRNSS4 Capital AGM statement
16th May 20253:01 pmRNSDirector/PDMR Shareholding
9th May 20252:30 pmRNSNotice of AGM
8th May 20257:00 amRNSS4 Capital Q1 2025 Trading Update
1st May 20257:00 amRNSBoard Appointments
25th Apr 202511:39 amRNSNotice of Q1 Trading Update
3rd Apr 20259:11 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSAudited 2024 Results
17th Mar 20257:00 amRNSNotice of Results
28th Jan 20257:00 amRNSFourth Quarter Trading Update
9th Jan 20257:00 amRNSManagement Change
2nd Dec 20243:55 pmRNSTotal Voting Rights
15th Nov 20243:30 pmRNSDirector/PDMR Shareholding
15th Nov 20247:00 amRNSIssue of Shares
7th Nov 20247:00 amRNSThird Quarter Trading Update
4th Nov 20247:00 amRNSNotice of Q3 Trading Update
1st Nov 20249:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSIssue of Shares
7th Oct 20247:00 amRNSIssue of Shares
19th Sep 20247:00 amRNSInterim Results for 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.